Skip to main content
. 2023 Sep 1;25:e46701. doi: 10.2196/46701

Figure 2.

Figure 2

Decentralized CT/NG/TV and SARS-CoV-2 point-of-care testing networks (2022). CT: Chlamydia trachomatis; NG: Neisseria gonorrhoeae; TV: Trichomonas vaginalis.